Nick Arjomand A High School Boy Creates Invasive Cancer Screening Method

Read Time:1 Minute, 14 Second

In this era of technology, nothing is impossible. Cancer is considered to be the most deadly disease, and it has taken millions of lives. Nick Arjomand is the student with the age of 15-years only, he introduces the lung cancer diagnosis method ” SimpliGene”.

For the non-invasive lung cancer of the primary stages, SimpliGene is known to be the first method in the whole world. It is the prototype, but in the future, it will use for the detection of all different types of cancer.

This test based on the latest technology and the most accurate results. Nick is a young boy and has less knowledge and experience about the screening.

Nick Arjomand(LinkedIn) is considering many companies to bring his test into the market. His primary purpose in making this test is to save the lives of the people who can’t be able to afford the expensive tests.

He wanted to show the world his capabilities, and he did it. His creation is the latest advancement in the treatment of cancer. SimpliGene is cost-effective and will save the lives of millions of people. It is not only the revolution in the oncology industry but also in the biotech industry.

Nick believes that it is just a start; in the future, there are many advance tests introduced to save the people from all types of cancer. And this test will help the oncologist to make effective treatment according to the findings of this test.